Finalists announced for OBN Awards celebrating life science firms

Finalists have been revealed for the 16th annual OBN Awards, celebrating outstanding achievement across the life science industry.

The awards are hosted by OBN, a membership organisation to support and bring together emerging life science companies, corporate partners and investors from across the UK.

Judges once again praised the ‘incredibly high’ quality and volume of entrants this year.

They’ll now decide on 10 winners, to be announced during a live ceremony at the Royal Lancaster London on 20 November.

This year’s finalists are as follows:

Best Startup Biotech Company (sponsored by Milton Park)

Ambrose Healthcare

CamGene Therapeutics

Tessellate BIO

Best Emerging Biotech Company (sponsored by Thermo Fisher Scientific)

AviadoBio

EyeBiotech

Ignota Labs

Best Established Biotech Company (sponsored by Precision for Medicine)

Adaptimmune

Bit.bio

Grey Wolf Therapeutics

Best Early Stage Medtech Company (sponsored by Penningtons Manches Cooper)

EarSwitch

Novai

Radiance Therapeutics

Best Established Medtech Company

Brainomix

Owlstone Medical

Perspectum

Most Transformative Healthtech Company of the Year

Brainomix

Cyted Health

Novai

Most Impactful CRO of the Year

Cellomatics Biosciences

ImmuONE

Oxford Biomedica

PHARMExcel

Most Impactful Industry Collaboration of the Year (sponsored by Mills & Reeve)

Pangaea Data

Poolbeg Pharma

The Cystic Fibrosis-AMR Syndicate

BioSeed 'One to Watch' Award (sponsored by Partners&)

Ignota Labs

Medisieve

MESOX

Vitarka Therapeutics

Best Industry Support Partner of the Year

Bulb Laboratories

First Create The Media

Mowbi

Partners&